Baseline characteristics of study participants
The final analytic cohort comprised 98 patients in the conventional group and 94 in the intervention group, with no missing value among the variables recorded in the available dataset. Baseline age, disease duration, sex, occupation, education level, diagnosis, surgical side, NRS, MMWS, ROM, grip strength, SCV, MCV, SNAP, two-point discrimination distance, SAS, and SDS were comparable between groups (P > 0.05, Table 2). However, residual confounding could not be excluded because this was a retrospective study and because BMI, comorbidities, surgical complexity, time from surgery to rehabilitation initiation, and medication use were not available in the dataset.
Comparison of joint function
The groups showed no significant differences in MMWS, ROM, or grip strength at T0 (P > 0.05). At T1 and T2, the intervention group showed higher MMWS than the conventional group (T1: 78.63 ± 8.84 vs. 69.69 ± 8.61; T2: 91.43 ± 4.77 vs. 82.06 ± 6.71; P < 0.001). Dorsiflexion ROM, palmar flexion ROM, and grip strength were also higher in the intervention group at T1 and T2 (P < 0.001). The adjusted group-by-time interaction was significant for MMWS (Wald χ2[2] = 32.16, P < 0.001), dorsiflexion ROM (χ2[2] = 17.55, P < 0.001), palmar flexion ROM (χ2[2] = 8.43, P = 0.015), and grip strength (χ2[2] = 13.06, P = 0.001). The adjusted MMWS differences between the intervention and conventional groups were 8.80 points at T1 (95% CI, 6.39–11.21; P < 0.001) and 9.23 points at T2 (95% CI, 7.58–10.88; P < 0.001). The corresponding adjusted differences were 6.13° and 8.04° for dorsiflexion ROM, 6.08° and 5.70° for palmar flexion ROM, and 4.31 kg and 3.96 kg for grip strength at T1 and T2, respectively (Figure 1).
For clinical context, the adjusted between-group MMWS differences were 8.8 points at T1 and 9.2 points at T2. A recently reported 11.5-point minimal clinically important difference (MCID) for the Mayo Wrist Score was derived after isolated carpal tunnel release and therefore cannot be applied directly to this heterogeneous cohort; neither adjusted MMWS difference exceeded that condition-specific threshold. The adjusted NRS differences of 0.6 and 0.9 points were below the approximately 1-point MCID reported for chronic musculoskeletal pain, while the adjusted grip-strength differences of 4.3 and 4.0 kg were below the 6.5-kg MCID reported after distal radius fracture. No validated diagnosis-independent MCID was identified for wrist ROM; these comparisons are therefore contextual rather than definitive because the published thresholds were derived in different populations and generally refer to within-patient change rather than between-group differences.
Comparative pain and safety assessments
The NRS score at T0 was similar between the groups (5.05 ± 1.63 vs. 5.28 ± 1.62, P = 0.336). At T1 and T2, the intervention group showed lower NRS scores than the conventional group (T1: 3.83 ± 1.15 vs. 4.40 ± 0.98; T2: 2.15 ± 0.82 vs. 3.03 ± 0.99; P < 0.001). The reduction from T0 to T2 was also greater in the intervention group (-3.13 ± 1.68 vs. -2.02 ± 1.94, P < 0.001). Postrehabilitation complications were numerically less frequent in the intervention group than in the conventional group, but the difference was not statistically significant (6.38% vs. 15.31%, P = 0.080; Table 3). The adjusted group-by-time interaction was significant for NRS scores (Wald χ2[2] = 18.19, P < 0.001). The adjusted between-group differences were −0.56 points at T1 (95% CI −0.85 to −0.26, P < 0.001) and −0.87 points at T2 (95% CI −1.13 to −0.61, P < 0.001).
Comparison of neurological functions
SCV, MCV, and SNAP were comparable between groups before rehabilitation (P > 0.05). After rehabilitation, the intervention group showed higher SCV (52.09 ± 6.19 vs. 47.30 ± 6.37, P < 0.001), MCV (52.13 ± 6.33 vs. 49.56 ± 6.27, P = 0.005), and SNAP (16.48 ± 2.73 vs. 14.33 ± 2.76, P < 0.001) than the conventional group. After adjustment for the corresponding baseline measurement, age, disease duration, sex, diagnosis, and surgical side, the intervention group had higher postrehabilitation SCV (adjusted difference, 4.62; 95% CI 2.73–6.51; Holm-adjusted P < 0.001), MCV (2.37; 95% CI 0.50–4.24; Holm-adjusted P = 0.013), and SNAP amplitude (2.29; 95% CI 1.48–3.10; Holm-adjusted P < 0.001), together with a shorter two-point discrimination distance (−2.59; 95% CI −3.24 to −1.94; Holm-adjusted P < 0.001; Figure 2).
Comparison of psychological status
Regarding psychological status, the conventional group showed little change in SAS and SDS scores after rehabilitation (P > 0.05). In the intervention group, both SAS and SDS scores decreased after rehabilitation and were lower than those in the conventional group (SAS: 37.70 ± 7.03 vs. 45.12 ± 8.95; SDS: 40.11 ± 6.65 vs. 48.00 ± 8.44; P < 0.001; Figure 3). After adjustment for the corresponding baseline score and the available covariates, the intervention group had lower postrehabilitation SAS scores (adjusted difference, −7.80; 95% CI −10.18 to −5.42; P < 0.001) and SDS scores (−8.08; 95% CI −10.30 to −5.86; P < 0.001).
Comparison of rehabilitation compliance and patient satisfaction
The intervention group showed a higher rehabilitation compliance rate than the conventional group (84.34 ± 7.24% vs. 76.04 ± 8.65%, P < 0.001). According to the satisfaction survey results, the overall distribution of satisfaction differed between groups (P = 0.029), and the proportion of patients who were satisfied or very satisfied was higher in the intervention group than in the conventional group (91.49% vs. 79.59%, P = 0.033; Table 4). Taken together, the adjusted findings were consistently more favorable for several functional, pain, neurophysiological, sensory, psychological, adherence, and satisfaction outcomes in the stepwise rehabilitation group; however, postrehabilitation complications did not differ significantly, and several statistically significant between-group differences did not exceed available condition-specific clinically meaningful thresholds, so the results should be interpreted as associative rather than as evidence of efficacy.
Data Availability
All raw data in this study have been uploaded as Supplementary Table S1.
FIGURES AND TABLES:

Figure 1: Functional outcomes according to rehabilitation pathway. The panels show comparisons of MMWS (A), ROM of dorsiflexion (B), ROM of palmar flexion (C), and grip strength (D) between the two groups at T0, T1, and T2. T0, before rehabilitation initiation; T1, 3 months after rehabilitation initiation; T2, 6 months after rehabilitation initiation. Data are presented as mean ± SD. aP < 0.05 compared with T0 within the same group; bP < 0.05 compared with T1 within the same group; cP < 0.05 compared with the conventional group. Combined letters indicate that the corresponding comparisons were statistically significant. Please click here to view a larger version of this figure.

Figure 2: Neurophysiological and sensory outcomes according to rehabilitation pathway. The panels show sensory conduction velocity (SCV; A), motor conduction velocity (MCV; B), sensory nerve action potential (SNAP) amplitude (C), and two-point discrimination distance (D) before and after rehabilitation. Data are presented as mean ± SD. Adjusted between-group differences were estimated using baseline-adjusted regression controlling for age, disease duration, sex, diagnosis, and surgical side; P values were adjusted across the four outcomes using the Holm method. aP < 0.05 compared with before rehabilitation within the same group; cP < 0.05 compared with the conventional group. Combined letters indicate that the corresponding comparisons were statistically significant. Please click here to view a larger version of this figure.

Figure 3: Psychological outcomes according to rehabilitation pathway. The panels show comparisons of SAS (A) and SDS (B) between the two groups before and after rehabilitation. Data are presented as mean ± SD. aP < 0.05 compared with before rehabilitation within the same group; cP < 0.05 compared with the conventional group. Please click here to view a larger version of this figure.
| Stage | Timing and primary goal | Rehabilitation content | Progression and adjustment criteria | Supervision and home rehabilitation |
| Protective immobilization | Early postoperative phase; pain and swelling control | Physical cooling; continuous passive wrist flexion and extension limited to 0°–30° | Progression was considered according to postoperative time, NRS score, swelling, wound condition, ROM, post-exercise tolerance, and the absence of aggravated pain or new neurological symptoms. If NRS was ≥4, swelling increased, or pain persisted after exercise, training intensity was reduced and reassessment was performed. | One supervised session per week, approximately 15 min per session; family-assisted home exercise and reporting of increased pain, swelling, wound abnormalities, or new neurological symptoms |
| Functional activation | After the early protective stage; active flexion and extension progressed toward approximately 60° by postoperative week 3 | Progressive active wrist flexion and extension within tolerance, with gradual advancement of functional use | The same symptom- and function-based criteria were used for progression; worsening pain, swelling, or neurological symptoms prompted reduction of training intensity and reassessment. | Weekly supervised rehabilitation combined with family-assisted home exercise |
| Intensive training | After achievement of functional-activation targets through completion of the 3-month rehabilitation period | Progressive functional training and wrist/grip strengthening according to recovery status and tolerance | Functional demand and strengthening were advanced only while pain, swelling, wound condition, exercise tolerance, and neurological status remained acceptable; NRS ≥4 or symptom aggravation prompted reduction of intensity and reassessment. | Weekly supervised rehabilitation combined with continued home exercise and family participation |
Table 1: Stage-specific components and progression criteria of the early stepwise rehabilitation pathway. Exact calendar cutoffs between stages and a fixed resistance-training dose were not consistently documented in the retrospective records; therefore, stage progression depended on postoperative timing and the clinical and functional criteria shown above. Abbreviations: NRS = Numeric Rating Scale; ROM = range of motion.
| | Intervention group | Conventional group | Statistical value | P value |
| | n=94 | n=98 | χ2 or t | |
| Age (years old) | | 45.61±10.58 | 45.65±11.29 | 0.03 | 0.977 |
| Sex | Male | 58 (61.70) | 52 (53.06) | 1.46 | 0.226 |
| Female | 36 (38.30) | 46 (46.94) | | |
| Type of occupation | Athletes | 22 (23.40) | 21 (21.43) | 0.81 | 0.668 |
| Office worker | 18 (19.15) | 24 (24.49) | | |
| Manual laborer | 54 (57.45) | 53 (54.08) | | |
| Level of education | < high school | 38 (40.43) | 34 (34.69) | 0.67 | 0.412 |
| ≥ high school | 56 (59.57) | 64 (65.31) | | |
| Types of wrist disorders | TFCC | 19 (20.21) | 18 (18.37) | 1.19 | 0.88 |
| Carpal tunnel syndrome | 15 (15.96) | 18 (18.37) | | |
| Wrist synovitis | 28 (29.79) | 24 (24.49) | | |
| Distal radius fracture | 28 (29.79) | 32 (32.65) | | |
| Other | 4 (4.26) | 6 (6.12) | | |
| Duration of disease (d) | | 18.29±5.42 | 19.34±4.86 | 1.41 | 0.159 |
| Side of operation | Left | 42 (44.68) | 40 (40.82) | 0.29 | 0.588 |
| Right | 52 (55.32) | 58 (59.18) | | |
Table 2: Baseline demographic, clinical, and pre-rehabilitation outcome characteristics of the study cohort. Note: Data are presented as mean ± standard deviation or n (%), as appropriate. Statistical values are presented as χ² or t values. Abbreviations: MMWS, Modified Mayo Wrist Score; NRS, Numeric Rating Scale; ROM, range of motion.
| | Intervention group | Conventional group | Statistical value | P value |
| | n=94 | n=98 | χ2 or t | |
| NRS | T0 | 5.28±1.62 | 5.05±1.63 | 0.96 | 0.337 |
| T1 | 3.83±1.15a | 4.40±0.98a | 3.69 | <0.001 |
| T2 | 2.15±0.82ab | 3.03±0.99ab | 6.72 | <0.001 |
| Complications | Stiff joints | 3 (3.19) | 8 (8.16) | | |
| Muscle atrophy | 2 (2.13) | 5 (5.10) | | |
| Heterotopic ossification | 1 (1.06) | 2 (2.04) | | |
| Total | 6.38% | 15.31% | 3.92 | 0.047 |
Table 3: Pain scores, changes in pain scores, and post-rehabilitation complications according to rehabilitation pathway. Note: Data are presented as mean ± standard deviation or n (%), as appropriate. NRS, Numeric Rating Scale; T0, before rehabilitation initiation; T1, 3 months after rehabilitation initiation; T2, 6 months after rehabilitation initiation. aP < 0.05 compared with T0 within the same group; bP < 0.05 compared with T1 within the same group. Statistical values are presented as χ² or t values, as appropriate. Abbreviation: NRS = Numeric Rating Scale.
| Intervention group | Conventional group | Statistical value | P value |
| n=94 | n=98 | χ2 or t | |
| Rehabilitation compliance rate | 84.34±7.24 | 76.04±8.65 | 7.2 | <0.001 |
| Very satisfied (5 points) | 46 (48.94) | 34 (34.69) | | |
| Satisfaction (3-4 points) | 40 (42.55) | 44 (44.90) | | |
| Not satisfied (1-2 points) | 8 (8.51) | 20 (20.41) | | |
| Satisfaction rate (3-5 points) | 91.49% | 79.59% | 5.45 | 0.02 |
Table 4: Rehabilitation compliance and patient satisfaction according to rehabilitation pathway. Note: Data are presented as mean ± standard deviation or n (%), as appropriate. Rehabilitation compliance rate is expressed as a percentage. Patient satisfaction was assessed using a 5-point satisfaction scale. The satisfaction rate represents the proportion of patients rated as satisfied or very satisfied (3–5 points). Statistical values are presented as χ² or t values, as appropriate.
Supplementary Table S1. Raw data used in this study. Please click here to download this file.